 |
인쇄하기
취소
|
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be...
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be expired patent drugs
Many major pharmaceutical firms are scurrying to introduce the first generic versions of soon-to-be expired patent drugs including simvastatin, glimepiride and amlodipine, in the hope of acquiring a lion's share of the patented drugs market in Korea.
1) Simvastatin: Although MSD...
Many major pharmaceutical firms are scurrying to introduce the first generic versions of soon-to-be expired patent drugs including simvastatin, glimepiride and amlodipine, in the hope of acquiring a lion's share of the patented drugs market in Korea.
1) Simvastatin: Although MSD...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.